What Happened?
Branford, CT-based IsoPlexis Appointed Sean Mackay as Co Founder and Chief Executive Officer
About the Company
IsoPlexis is leading a new era of functional proteomics. By identifying our most proteomically active single cells (or "superhero cells") for the first time, IsoPlexis enables researchers to connect more directly to in vivo biology and develop more precise and personalized therapies. IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at the majority of leading U.S. comprehensive cancer centers.
About the Person
Sean Mackay is Co Founder and Chief Executive Officer at IsoPlexis. Previously, Sean held various senior HR leadership roles in the industry.
Info Source
News
Short Profile